Rohit Bose
Overview
Explore the profile of Rohit Bose including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bose R, Petersen B, Sarma D, Barra B, Nanivadekar A, Madonna T, et al.
medRxiv
. 2025 Jan;
PMID: 39802790
Background: The goal of this study was to examine the effects of spinal cord stimulation (SCS) on muscle activity during walking after lower-limb amputation. Amputation results in a loss of...
2.
Jindal T, Jiang C, Alhalabi O, Nizam A, Nguyen C, Talukder R, et al.
Eur Urol Oncol
. 2024 Dec;
PMID: 39709257
Enfortumab vedotin (EV) is used as monotherapy or combined with pembrolizumab in advanced urothelial carcinoma (aUC), but biomarker data associated with EV outcomes are limited. We identified 170 patients in...
3.
Kwon D, Trihy L, Darvish N, Hearst E, Sumra S, Borno H, et al.
Cancer Med
. 2024 Nov;
13(22):e70433.
PMID: 39569542
Introduction: Consultation audio recordings improve patient decision-making but are underutilized. Patient-administered recording apps on mobile devices may increase access, but implementation has not been evaluated. Methods: We conducted a single-arm...
4.
Nanivadekar A, Bose R, Petersen B, Okorokova E, Sarma D, Madonna T, et al.
Nat Biomed Eng
. 2023 Dec;
8(11):1502.
PMID: 38155296
No abstract available.
5.
Nanivadekar A, Bose R, Petersen B, Okorokova E, Sarma D, Madonna T, et al.
Nat Biomed Eng
. 2023 Dec;
8(8):992-1003.
PMID: 38097809
Restoring somatosensory feedback in individuals with lower-limb amputations would reduce the risk of falls and alleviate phantom limb pain. Here we show, in three individuals with transtibial amputation (one traumatic...
6.
Aggarwal R, Starzinski S, de Kouchkovsky I, Koshkin V, Bose R, Chou J, et al.
Lancet Oncol
. 2023 Nov;
24(11):1266-1276.
PMID: 37922930
Background: Checkpoint inhibitors have been shown to have limited activity in patients with metastatic castration-resistant prostate cancer. We aimed to determine whether a single dose of lutetium-177 [Lu]-prostate-specific membrane antigen...
7.
Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, et al.
Clin Genitourin Cancer
. 2023 Jun;
21(5):e394-e404.
PMID: 37316414
Introduction: Urothelial carcinoma with squamous differentiation (UCS) is associated with increased resistance to chemotherapy, but outcomes associated with newer therapies approved in this space over the last 5 to 10...
8.
Jindal T, Zhu X, Bose R, Kumar V, Maldonado E, Deshmukh P, et al.
Front Oncol
. 2023 Apr;
13:1161089.
PMID: 37091148
Background: Enfortumab vedotin (EV) is an antibody-drug conjugate approved for patients with treatment-refractory advanced urothelial carcinoma (aUC), however data on biomarkers of response is lacking. Methods: We retrospectively identified all...
9.
Ding K, Chen Y, Bose R, Osborn L, Dragomir A, Thakor N
Sci Rep
. 2022 Nov;
12(1):20467.
PMID: 36443387
Touch-like phantom limb sensations can be elicited through targeted transcutaneous electrical nerve stimulation (tTENS) in individuals with upper limb amputation. The corresponding impact of sensory stimulation on cortical activity remains...
10.
Kwon D, Shakhnazaryan N, Shui D, Hong J, Mohamad O, de Kouchkovsky I, et al.
Urol Oncol
. 2022 Nov;
41(3):145.e7-145.e15.
PMID: 36435709
Background: Radiopharmaceuticals, including Ga-68-prostate specific membrane antigen (PSMA)-11 and F-18-Fluciclovine, are increasingly used to inform therapies for prostate cancer (CaP). Stereotactic body radiation therapy (SBRT) to PET-detected oligometastatic CaP has...